HOME >> BIOLOGY >> NEWS
Robust time estimation reconciles views of the antiquity of placental mammals

Despite great progress over the past decade, the evolutionary history of placental mammals remains controversial. While a consensus is emerging on the topology of the evolutionary tree, although with occasional disagreement, divergence times remain uncertain. The age of earlier nodes and in particular the root, remain especially uncertain in the absence of definitive placental fossils deeper into the Cretaceous. Both paleontological and morphological studies suggest that the radiation of placental orders and super orders occurred close to the CretaceousTertiary (KT) boundary about 65 million years ago (mya). In contrast, molecular studies have suggested markedly older origins for many superordinal groups and that some extant orders diversified before the KT boundary.

However, this discrepancy may not be real, but rather appear because of the violation of implicit assumptions in the estimation procedures, such as abrupt acceleration of evolutionary rate entangled with gradual variation and large-scale convergent evolution in molecular level. By their new robust procedure, Dr. Kitazoe and his collaborators identified a strong and short-term acceleration of mitochondrial genome along the lineage leading to Laurasiatheria. The revised time at the root of placental mammals was much younger than the preceding reports, 84 million years ago instead of around 122 million years ago. As a result, the estimated distribution of molecular divergence times is broadly consistent with quantitative analysis of the North American fossil record and traditional morphological views. They emphasize the necessity to scrutinize the implicit assumptions adopted by the models of molecular evolution and to develop procedures which rely little on those assumptions.


'"/>

Contact: Yasuhiro Kitazoe
kitazoey@kochi-u.ac.jp
Public Library of Science
17-Apr-2007


Page: 1

Related biology news :

1. Local range estimation in wild animals
2. Neuroblastoma expert reviews progress and challenges in fighting difficult pediatric cancer
3. New findings challenge established views on human genome
4. New findings challenge established views about human genome
5. Public shares views on environmental, health and safety research needs for nanoscale materials
6. Handling HPV vaccines and screening: The views of 100 authors
7. Through a satellite darkly: Night views of European seas improve ESA ocean heat map
8. Avian flu in perspective: New England Journal article reviews spectacular findings
9. New study into public views on diet and health research published
10. Technological revolutions in sensors, robotics, and telecommunications allow new views of ocean
11. New study highlights universality of public views toward science and technology

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: